SierraSil Joint Formula 14 as an Ergogenic Aid to Performance in Athletes
NCT ID: NCT01932281
Last Updated: 2015-07-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2014-05-31
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A secondary purpose is to examine the effect of SierraSil on the severity of delayed onset muscle soreness.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Spirulina Supplementation In Recovery From Damaging Exercise
NCT06391957
Effects of Zeolite + Dolomite on Performance and Acidosis
NCT01831492
The Effects of 10 Days of Extreme Endurance on Performance
NCT03337737
Combined Effect of Exercise Intensity With Nutritional Supplementation on Skeletal Muscle Function
NCT05350566
Effects of a Multi-Ingredient Pre-Workout Supplement on Body Composition, Performance, Muscular Properties, and Wellbeing in Adults.
NCT05769088
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SierraSil
SierraSil will be given in a dosage of 3 to 5, 667 mg capsules, according to body weight, daily for 3 weeks.
SierraSil
SierraSil is a natural, mineral supplement currently used to improve joint health and function.
Placebo
This is a sugar pill and will be given in a dosage of 3 to 5 capsules daily for 3 weeks.
Placebo
Sugar pill manufactured to mimic SierraSil 667 mg capsule
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SierraSil
SierraSil is a natural, mineral supplement currently used to improve joint health and function.
Placebo
Sugar pill manufactured to mimic SierraSil 667 mg capsule
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* taking any form of anti-inflammatory or pain medication
* females due to the variability that might be introduced due to the phases of the menstrual cycle
19 Years
35 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Donald C. McKenzie, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of British Columbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of British Columbia
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H13-00121
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.